Search

everythinglearnresearchcommunity

for

Search:↓

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

An 11-year-old girl with Kawasaki disease experienced hair loss that improved after treatment.

A woman's sudden hair loss was linked to her previous COVID-19 infection.

COVID-19 doesn't make alopecia areata worse.

Some medications can cause reversible hair loss by affecting hair growth cycles.

Painful hair loss in an elderly woman was caused by giant cell arteritis, not just aging.

Platelet-Rich Plasma therapy helped significantly in hair recovery for a hair loss condition after infection.

Proper medical treatments can control and even reverse female pattern hair loss, but it's important to check for related conditions like excessive male hormone production, especially in severe cases.

Scalp biopsies are essential for accurately diagnosing alopecia areata.

Taking fluconazole for fungal infections might cause hair loss after about 3 months.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Alopecia linked to higher anxiety and personality disorders.

Some medications can cause hair loss, and it's important to track when the hair loss starts after taking a new medication.

Patients with systemic lupus erythematosus and hair loss had non-scarring alopecia with fewer hair follicles, and direct immunofluorescence did not help identify lupus.

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

The document concludes that severe trauma can cause temporary hair loss, known as Telogen Effluvium, which usually resolves without treatment.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

The document concludes that most patients with endocrine disorders experience diffuse, non-scarring hair loss, with scarring hair loss being rare.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

Physical exams are important in hair loss diagnosis, considering cosmetic history, systemic diseases, and classifying alopecia types.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Systemic diseases can cause hair loss, which is often reversible with treatment.

About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.

Common baldness treatments include cosmetic methods, medication like minoxidil, and surgery, but no cure exists.

The issue concluded that various skin conditions have different effective treatments and factors influencing them.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.